NasdaqGM:AVBPBiotechs
Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum Shift
Why ArriVent BioPharma (AVBP) is on investors’ radar
ArriVent BioPharma (AVBP) has drawn attention after recent trading, with the stock last closing at US$21.43 and showing mixed short term performance across the past week, month, and past 3 months.
See our latest analysis for ArriVent BioPharma.
At the current share price of US$21.43, ArriVent BioPharma’s recent 30 day share price return of a 7.99% decline contrasts with a 3.03% year to date share price gain and a 13.09% total shareholder...